The market's overconfidence in the business a year ago is evident as the EPS reduction isn't as severe as the share price drop. The company's five-year performance led to a 5% annual loss for shareholders. Investors should monitor the fundamentals for potential opportunities.
The company's investments are not yielding high returns despite increased capital employed. The rise in current liabilities and the stock's 17% loss in the last five years indicate market skepticism about future improvements.
Despite China Resources Medical Holdings' declining earnings, the high P/E ratio points to investors' optimism for a bounce-back, backed by strong growth expectations. Hard to see share price falling soon.
$鳳凰医療(01515.HK)$ China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and exter...
$国薬(01099.HK)$ Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...
鳳凰医療に関するコメント
China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and exter...
Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...
DBS: China Healthcare Sector – Pharmaceutical Packaging
$微創医療科学(00853.HK)$$山東威高(01066.HK)$$石薬集団(01093.HK)$$国薬(01099.HK)$$鳳凰医療(01515.HK)$$康臣薬業(01681.HK)$$春立医療(01858.HK)$$環球医療(02666.HK)$$復宏漢霖(02696.HK)$$B-Soft Co.,Ltd.(300451.SZ)$$Guangxi LiuYao Group(603368.SH)$$百済神州(06160.HK)$
DBS: China Biotech Sector
$百済神州(06160.HK)$$石薬集団(01093.HK)$$復宏漢霖(02696.HK)$$微創医療科学(00853.HK)$$山東威高(01066.HK)$$国薬(01099.HK)$$鳳凰医療(01515.HK)$$康臣薬業(01681.HK)$$春立医療(01858.HK)$$環球医療(02666.HK)$$復宏漢霖(02696.HK)$$B-Soft Co.,Ltd.(300451.SZ)$$Guangxi LiuYao Group(603368.SH)$$百済神州(06160.HK)$
DBS: China Resources Medical Holdings Co Ltd – BUY TO HK$9.40
$鳳凰医療(01515.HK)$
まだコメントはありません